Marilena A. Romero

Chieti, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.

Journal: Therapeutic advances in hematology

Published: November 20, 2020

Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population-Based Cohort Study.

Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population-Based Cohort Study.

Journal: The oncologist

Published: March 17, 2020

Effectiveness and Costs Associated to Adding Cetuximab or Bevacizumab to Chemotherapy as Initial Treatment in Metastatic Colorectal Cancer: Results from the Observational FABIO Project.

Effectiveness and Costs Associated to Adding Cetuximab or Bevacizumab to Chemotherapy as Initial Treatment in Metastatic Colorectal Cancer: Results from the Observational FABIO Project.

Journal: Cancers

Published: March 03, 2020

Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.

Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.

Journal: The Lancet. Infectious diseases

Published: January 17, 2019

Persistence of Central Venous Oxygen Desaturation During Early Sepsis Is Associated With Higher Mortality: A Retrospective Analysis of the ALBIOS Trial.

Persistence of Central Venous Oxygen Desaturation During Early Sepsis Is Associated With Higher Mortality: A Retrospective Analysis of the ALBIOS Trial.

Journal: Chest

Published: December 07, 2017

Regulation of signaling pathways by tanshinones in different cancers.

Regulation of signaling pathways by tanshinones in different cancers.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: September 30, 2017

Signaling networks in TMPRSS2-ERG positive prostate cancers: Do we need a Pied Piper or sharpshooter to deal with "at large" fused oncoprotein.

Signaling networks in TMPRSS2-ERG positive prostate cancers: Do we need a Pied Piper or sharpshooter to deal with "at large" fused oncoprotein.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: March 23, 2017

Reply to O. Corli et al and M. Lucchesi et al.

Reply to O. Corli et al and M. Lucchesi et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2016

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain.

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 09, 2015

Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.

Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.

Journal: Critical care medicine

Published: November 17, 2015

Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.

Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.

Journal: Intensive care medicine

Published: July 18, 2015

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

Journal: BMC urology

Published: March 05, 2015

Showing 1-12 of 31

Last Updated: 09/26/2026